Evonik Acquires SurModics Pharmaceuticals

  • Author: ChemistryViews
  • Published: 03 November 2011
  • Copyright: WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Evonik Industries AG
  • Associated Suppliers: Evonik Industries AG, Essen, Germany
thumbnail image: Evonik Acquires SurModics Pharmaceuticals

Evonik  has reached an agreement to acquire SurModics Pharmaceuticals, Inc., Birmingham, USA, an affiliate of SurModics, Inc. Signing took place on November 1, 2011 and the transaction is expected to close shortly.

SurModics Pharmaceuticals designs and produces bio-resorbable polymers marketed under the brand Lakeshore Biomaterials and possesses expertise and facilities to carry out all phases of pharmaceutical product development up to commercial manufacturing. The business focuses on the development of injectable drug-delivery systems that systemically or locally release active pharmaceutical ingredients (API) within a period of up to several months. Formulation approaches include bio-resorbable microparticles, nanoparticles, liposomes, implants and other polymer-based configurations.

The company employs approximately 80 pharmaceutical experts. In 2010, the total revenues amounted to more than $15 million.

Article Views: 2670

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more

Follow on Facebook Follow on Twitter Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH